208 related articles for article (PubMed ID: 35164638)
21. Prognostic value of visceral pleural invasion in the stage pT
Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
[TBL] [Abstract][Full Text] [Related]
22. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
Zell JA; Ou SH; Ziogas A; Anton-Culver H
Cancer; 2008 Jan; 112(1):136-43. PubMed ID: 17960795
[TBL] [Abstract][Full Text] [Related]
23. Do older patients with stage IB non-small-cell lung cancer obtain survival benefits from surgery? A propensity score matching study using SEER data.
Ye X; Liu Y; Yang J; Wang Y; Cui X; Xie H; Song L; Ding Z; Zhai R; Han Y; Yang L; Zhang H
Eur J Surg Oncol; 2022 Sep; 48(9):1954-1963. PubMed ID: 35379544
[TBL] [Abstract][Full Text] [Related]
24. A propensity score matching analysis of survival following segmentectomy or wedge resection in early-stage lung invasive adenocarcinoma or squamous cell carcinoma.
Zhang Y; Sun Y; Chen H
Oncotarget; 2016 Mar; 7(12):13880-5. PubMed ID: 26871600
[TBL] [Abstract][Full Text] [Related]
25. Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
Bao Y; Yang X; Men Y; Kang J; Sun X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
Thorac Cancer; 2022 Feb; 13(3):404-411. PubMed ID: 34907665
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of examined lymph node count in older patients with stage T1N0M0 pulmonary carcinoid tumours: a population-based propensity score-matched analysis.
Yang H; Fang Z; Liu T; Zhu X; Luo L
Aging Clin Exp Res; 2023 Jan; 35(1):203-212. PubMed ID: 36319940
[TBL] [Abstract][Full Text] [Related]
27. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
[TBL] [Abstract][Full Text] [Related]
28. Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
Wei S; Xie M; Tian J; Song X; Wu B; Liu L
Radiat Oncol; 2017 Jun; 12(1):96. PubMed ID: 28610591
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of radiofrequency ablation therapy for patients with unresected Stage IA non-small cell lung cancer.
Li M; Qin Y; Mei A; Wang C; Fan L
J Cancer Res Ther; 2020 Sep; 16(5):1007-1013. PubMed ID: 33004741
[TBL] [Abstract][Full Text] [Related]
30. Effect of preoperative radiotherapy on overall survival in N2 non-small-cell lung cancer: a propensity score-matched analysis of Surveillance, Epidemiology, and End Results database.
Wang Y; Cao Y; Wu M; Lu Y; He B; Zhou L; Hu W
Interact Cardiovasc Thorac Surg; 2022 Jun; 35(1):. PubMed ID: 35639970
[TBL] [Abstract][Full Text] [Related]
31. Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer.
Zhu J; Sharma DB; Gray SW; Chen AB; Weeks JC; Schrag D
JAMA; 2012 Apr; 307(15):1593-601. PubMed ID: 22511687
[TBL] [Abstract][Full Text] [Related]
32. The Population-based Impact of Adjuvant Chemotherapy on Outcomes in T2N0M0 Non-Small Cell Lung Cancer.
Arora RK; Gibson AW; Bebb DG; Cheung WY
Am J Clin Oncol; 2020 Jul; 43(7):496-503. PubMed ID: 32349021
[TBL] [Abstract][Full Text] [Related]
33. Lobe-specific analysis of perioperative chemotherapy for non-small cell lung cancer patients.
Lei X; Li T; Mao F; Ren F; Tang Q; Cao W; Zu L; Xu S
Cancer Med; 2023 Aug; 12(16):16896-16905. PubMed ID: 37403701
[TBL] [Abstract][Full Text] [Related]
34. The impact of order with radiation therapy in stage IIIA pathologic N2 NSCLC patients: a population-based study.
Duan H; Liang L; Xie S; Wang C
BMC Cancer; 2020 Aug; 20(1):809. PubMed ID: 32847544
[TBL] [Abstract][Full Text] [Related]
35. Construction of a Nomogram After Using Propensity Score Matching to Reveal the Prognostic Benefit of Tumor Resection of Stage IV M1a Nonsmall Cell Lung Cancer Patients.
Yin G; Xiao H; Liao Y; Huang C; Fan X
Cancer Invest; 2020 May; 38(5):277-288. PubMed ID: 32267175
[TBL] [Abstract][Full Text] [Related]
36. Ablation Therapy for Advanced Stage Non-Small Cell Lung Cancer: A National Cancer Database Study.
Halsey K; Wu J; Su C; Hsieh B; Yi T; Collins SA; Kimia B; Zhang PJ; Healey T; Zhang Z; Bai HX
J Vasc Interv Radiol; 2020 Aug; 31(8):1210-1215.e4. PubMed ID: 32460964
[TBL] [Abstract][Full Text] [Related]
37. Radical local treatment for stage IV non-small cell lung cancer in older adults: a propensity-score matched analysis of the SEER database.
Qiu C; Zhang S; Jin H; Zhang X; Ye J
Transl Cancer Res; 2020 Sep; 9(9):5336-5349. PubMed ID: 35117899
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registry.
Yang X; Sun F; Chen L; Shi M; Shi Y; Lin Z; Feng M; Zhan C; Jiang W; Wang Q
J Surg Oncol; 2017 Sep; 116(3):398-406. PubMed ID: 28543219
[TBL] [Abstract][Full Text] [Related]
39. Advanced age is not the decisive factor in chemotherapy of small cell lung cancer: a population-based study.
Rao H; Zhou S; Mei A; Yao A; Xie S
Aging (Albany NY); 2022 Jun; 14(11):4827-4838. PubMed ID: 35680571
[TBL] [Abstract][Full Text] [Related]
40. Postoperative chemotherapy significantly improves survival of elderly patients with stage IB-II non-small cell lung cancer: A population-based study.
Liu W; Ma S; Shi P; Zhang Y; Li M
Cancer Med; 2023 May; 12(10):11254-11263. PubMed ID: 37031456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
